Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

enVVeno Medical (NVNO) Operating Expenses (2017 - 2020)

enVVeno Medical has reported Operating Expenses over the past 4 years, most recently at $4.2 million for Q4 2020.

  • Quarterly results put Operating Expenses at $4.2 million for Q4 2020, up 143.16% from a year ago — trailing twelve months through Dec 2020 was $9.1 million (up 28.34% YoY), and the annual figure for FY2025 was $20.9 million, down 12.28%.
  • Operating Expenses for Q4 2020 was $4.2 million at enVVeno Medical, up from $1.9 million in the prior quarter.
  • Over the last five years, Operating Expenses for NVNO hit a ceiling of $4.2 million in Q4 2020 and a floor of $1.3 million in Q2 2017.
  • Median Operating Expenses over the past 4 years was $1.7 million (2017), compared with a mean of $1.9 million.
  • Biggest five-year swings in Operating Expenses: soared 151.48% in 2018 and later crashed 38.66% in 2019.
  • enVVeno Medical's Operating Expenses stood at $2.0 million in 2017, then decreased by 24.73% to $1.5 million in 2018, then rose by 13.27% to $1.7 million in 2019, then soared by 143.16% to $4.2 million in 2020.
  • The last three reported values for Operating Expenses were $4.2 million (Q4 2020), $1.9 million (Q3 2020), and $1.5 million (Q2 2020) per Business Quant data.